Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance
- PMID: 32882208
- DOI: 10.1016/j.ajog.2020.08.108
Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance
Abstract
Qualitative and quantitative measurement of urine protein excretion is one of the most common tests performed during pregnancy. For more than 100 years, proteinuria was necessary for the diagnosis of preeclampsia, but recent guidelines recommend that proteinuria is sufficient but not necessary for the diagnosis. Still, in clinical practice, most patients with gestational hypertension will be diagnosed as having preeclampsia based on the presence of proteinuria. Although the reference standard for measuring urinary protein excretion is a 24-hour urine collection, spot urine protein-to-creatinine ratio is a reasonable "rule-out" test for proteinuria. Urine dipstick screening for proteinuria does not provide any clinical benefit and should not be used to diagnose proteinuria. The classic cutoff cited to define proteinuria during pregnancy is a value of >300 mg/24 hours or a urine protein-to-creatinine ratio of at least 0.3. Using this cutoff, the rate of isolated proteinuria in pregnancy may reach 8%, whereas preeclampsia occurs among 3% to 8% of pregnancies. Although this threshold is widely accepted, its origin is not based on evidence on adverse pregnancy outcomes but rather on expert opinion and results of small studies. After reviewing the available data, the most important factor that influences maternal and neonatal outcome is the severity of blood pressures and presence of end organ damage, rather than the excess protein excretion. Because the management of gestational hypertension and preeclampsia without severe features is almost identical in frequency of surveillance and timing of delivery, the separation into 2 disorders is unnecessary. If the management of women with gestational hypertension with a positive assessment of proteinuria will not change, we believe that urine assessment for proteinuria is unnecessary in women who develop new-onset blood pressure at or after 20 weeks' gestation. Furthermore, we do not recommend repeated measurement of proteinuria for women with preeclampsia, the amount of proteinuria does not seem to be related to poor maternal and neonatal outcomes, and monitoring proteinuria may lead to unindicated preterm deliveries and related neonatal complications. Our current diagnosis of preeclampsia in women with chronic kidney disease may be based on a change in protein excretion, a baseline protein excretion evaluation is critical in certain conditions such as chronic hypertension, diabetes, and autoimmune or other renal disorders. The current definition of superimposed preeclampsia possesses a diagnostic dilemma, and it is unclear whether a change in the baseline proteinuria reflects another systemic disease such as preeclampsia or whether women with chronic disease such as chronic hypertension or diabetes will experience a different "normal" pattern of protein excretion during pregnancy. Finally, limited data are available regarding angiogenic and other biomarkers in women with chronic kidney disease as a potential aid in distinguishing the worsening of baseline chronic kidney disease and chronic hypertension from superimposed preeclampsia.
Keywords: 24-hour urine collection; biomarker; chronic hypertension; diagnosis; gestational hypertension; hypertensive disorder of pregnancy; podocytes; preeclampsia; pregnancy; pregnancy outcome; prognosis; proteinuria; renal disease; superimposed preeclampsia; urine protein-to-creatinine ratio.
Published by Elsevier Inc.
Comment in
-
Proteinuria in pregnancy: much ado about nothing.Am J Obstet Gynecol. 2021 Apr;224(4):421. doi: 10.1016/j.ajog.2020.11.018. Epub 2020 Nov 16. Am J Obstet Gynecol. 2021. PMID: 33207234 No abstract available.
-
Proteinuria in pregnancy: much ado about nothing, a response.Am J Obstet Gynecol. 2021 Apr;224(4):422. doi: 10.1016/j.ajog.2020.11.015. Epub 2020 Nov 16. Am J Obstet Gynecol. 2021. PMID: 33212038 No abstract available.
Similar articles
-
Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.Am J Obstet Gynecol. 2021 May;224(5):518.e1-518.e11. doi: 10.1016/j.ajog.2020.11.004. Epub 2020 Nov 6. Am J Obstet Gynecol. 2021. PMID: 33166504
-
Changes in proteinuria and diagnosing preeclampsia in CKD pregnancy.Pregnancy Hypertens. 2020 Apr;20:92-95. doi: 10.1016/j.preghy.2020.03.005. Epub 2020 Mar 10. Pregnancy Hypertens. 2020. PMID: 32203727
-
Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis.Health Technol Assess. 2017 Oct;21(61):1-90. doi: 10.3310/hta21610. Health Technol Assess. 2017. PMID: 29064366 Free PMC article. Review.
-
Clinical significance of proteinuria in pregnancy.Obstet Gynecol Surv. 2007 Feb;62(2):117-24. doi: 10.1097/01.ogx.0000253301.55009.ac. Obstet Gynecol Surv. 2007. PMID: 17229328 Review.
-
A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia.Hypertens Pregnancy. 2004;23(2):135-42. doi: 10.1081/PRG-120028289. Hypertens Pregnancy. 2004. PMID: 15369647
Cited by
-
Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications.Front Pharmacol. 2023 Nov 22;14:1281382. doi: 10.3389/fphar.2023.1281382. eCollection 2023. Front Pharmacol. 2023. PMID: 38074158 Free PMC article. No abstract available.
-
A study of adverse maternal-foetal outcomes in nephrotic syndrome combined with preeclampsia.BMC Pregnancy Childbirth. 2023 Nov 7;23(1):773. doi: 10.1186/s12884-023-06073-8. BMC Pregnancy Childbirth. 2023. PMID: 37936071 Free PMC article.
-
Pregnancy in Living Kidney Donors: An Evidence-Based Review.Curr Transplant Rep. 2023 Sep;10(3):110-116. doi: 10.1007/s40472-023-00402-8. Epub 2023 Aug 17. Curr Transplant Rep. 2023. PMID: 37743976
-
Kidney Biopsy in a Pregnant Patient with Suspected Glomerular Disease: PRO.Kidney360. 2023 Oct 1;4(10):1353-1355. doi: 10.34067/KID.0000000000000242. Kidney360. 2023. PMID: 37578499 Free PMC article. No abstract available.
-
Natriuretic Peptide Signaling in Uterine Biology and Preeclampsia.Int J Mol Sci. 2023 Aug 1;24(15):12309. doi: 10.3390/ijms241512309. Int J Mol Sci. 2023. PMID: 37569683 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical